• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Funding roundup: Echo Therapeutics, SeraCare and Avedro

Funding roundup: Echo Therapeutics, SeraCare and Avedro

January 6, 2011 By MassDevice staff

Funding roundup

Echo Therapeutics Inc. (OTC:ECTE), SeraCare Life Sciences Inc. (NSDQ:SRLS) and Avedro Inc. all brought in new funding this week.

Echo Therapeutics

Franklin, Mass.-based Echo raised $2.5 million via a private stock and warrants offering, with a binding commitment for another $3 million.

The company’s largest backer, Platinum Montaur Life Sciences LLC, led the round’s investors, according to Echo.

The company, which is developing a transdermal drug delivery device, plans to fund product development and clinical studies and support general corporate expenses with the new financing.

“The completion of this financing is a watershed event for the company, as we believe that we now have sufficient funds to substantially complete the product development, clinical studies and manufacturing of both our Prelude SkinPrep System, our skin permeation platform technology and our Symphony tCGM System, our needle-free continuous glucose monitoring system,” Echo CEO Dr. Patrick Mooney said in prepared remarks.

SeraCare Life Sciences

Milford, Mass.-based SeraCare secured a $20 million loan through a combination of credit facilities from Middlesex Savings Bank and Commerce Bank and Trust Co., which will provide $12 million and $8 million, respectively.

The life sciences service provider said it can use the funds, which are subject to the terms of the loan agreement, for working capital, acquisitions, stock repurchases and other general corporate purposes.

Avedro

Waltham-based vision correction start-up Avedro drummed up $1.7 million from a securities offering it first opened in July, according to an amended Securities & Exchange Commission filing.

The planned $8 million offering had already brought in $4.6 million, which brings the total funding for the round to $6.3 million.

The filing lists as directors Borealis Ventures’ Philip Ferneau, Prism VentureWorks’ Anthony Natale, De Novo Ventures’ Joseph Mandato, Flagship Ventures’ Doug Cole and Carl Johnson III of the Campbell Soup Company, in additiont to Avedro founder and CEO David Muller and CFO Rhonda Bracey.

Avedro won CE Mark approval in April for its Vedera system for performing Keraflex treatments designed to flatten the cornea in patients with myopia or keratoconus.

Filed Under: Business/Financial News, Diagnostics, News Well Tagged With: Echo Therapeutics Inc., SeraCare Life Sciences Inc.

More recent news

  • Neuralink files to raise $649M in new equity offering
  • BofA: Surgical robot remanufacturing not a major setback for Intuitive
  • InspireMD wins CE Mark approval for CGuard Prime
  • Philips reports first cases for VeriSight Pro 3D ICE catheter in Europe
  • Ceryx Medical raises $15M to support bioelectronic pacemaker

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy